Semper Paratus Acquisition (LGSTW) Competitors $0.07 0.00 (-4.29%) As of 03/7/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends LGSTW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXWShould you be buying Semper Paratus Acquisition stock or one of its competitors? The main competitors of Semper Paratus Acquisition include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry. Semper Paratus Acquisition vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Semper Paratus Acquisition (NASDAQ:LGSTW) and 180 Life Sciences (NASDAQ:ATNFW) are both financial services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability. Does the MarketBeat Community believe in LGSTW or ATNFW? Semper Paratus Acquisition and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformSemper Paratus AcquisitionN/AN/A180 Life SciencesN/AN/A Which has better earnings & valuation, LGSTW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSemper Paratus AcquisitionN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the media favor LGSTW or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than Semper Paratus Acquisition. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Semper Paratus Acquisition. 180 Life Sciences' average media sentiment score of 1.87 beat Semper Paratus Acquisition's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Semper Paratus Acquisition Neutral 180 Life Sciences Very Positive Is LGSTW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Semper Paratus AcquisitionN/A N/A N/A 180 Life Sciences N/A N/A N/A Summary180 Life Sciences beats Semper Paratus Acquisition on 2 of the 2 factors compared between the two stocks. Remove Ads Get Semper Paratus Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for LGSTW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LGSTW vs. The Competition Export to ExcelMetricSemper Paratus AcquisitionShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$36.57M$4.11B$8.08BDividend YieldN/A4.81%4.29%4.04%P/E RatioN/A0.5415.8518.99Price / SalesN/A464.421,748.43120.64Price / CashN/A217.8148.9934.64Price / BookN/A92.013.334.26Net IncomeN/A-$141.08M$1.27B$247.00M7 Day PerformanceN/A-0.07%-0.68%-1.60%1 Month PerformanceN/A-1.58%4.99%-9.68%1 Year PerformanceN/A4.18%10.18%1.96% Semper Paratus Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LGSTWSemper Paratus AcquisitionN/A$0.07-4.3%N/A-24.7%$0.00N/A0.003Gap DownHigh Trading VolumeATNFW180 Life SciencesN/A$0.01-18.0%N/A+34.9%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$12.72-0.1%N/AN/A$0.00N/A0.0018Analyst ForecastAnalyst RevisionNews CoverageGap UpAEHAWAesther Healthcare AcquisitionN/A$0.03-3.9%N/A-93.3%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.09-57.7%N/A+79.7%$0.00$40,633.000.0040Positive NewsGap UpALVOWAlvotechN/A$2.02-8.2%N/A-58.0%$0.00$391.87M0.004Short Interest ↑ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03-2.9%N/AN/A$0.00N/A0.004BFRIWBiofronteraN/A$0.06-41.9%N/A-6.0%$0.00$35.36M0.0070Positive NewsGap DownBTMDWbioteN/A$0.08-22.7%N/A-89.4%$0.00$193.06M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.11-5.9%N/A-92.7%$0.00N/A0.008Short Interest ↑News CoveragePositive NewsGap Down Remove Ads Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aardvark Therapeutics Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LGSTW) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semper Paratus Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semper Paratus Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LGSTW Stock Alerts